CNSP- Cns Pharmaceuticals, Inc.

Over the past 90 days, insiders at Cns Pharmaceuticals, Inc. (CNSP) have been net buyers, picking up 7,100 shares worth roughly $34K on balance.

CNSP sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Levin Rami	19.0K	$104.5K	-
CEO	Climaco John M	9.8K	$53.7K	-
Dir	Charles Faith L.	7.1K	$39.0K	-
CFO	Downs Christopher	4.9K	$26.8K	-
?	Mahery Amy	1.5K	$8.3K	-

Buys and sells only

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 18, 2026	Charles Faith L.50	Director	Buy	7,100	$4.79	$34,001.90	New	-	-
Feb 1, 2024	Evans Carl Anthony	Director	Buy	33,333	$0.30	$9,999.90	+26,666%	-13.7%	-99.2%
Feb 1, 2024	Downs Christopher	Chief Financial Officer	Buy	66,666	$0.30	$19,999.80	+181.3%	-13.7%	-99.2%
Feb 1, 2024	Climaco John M	Chief Executive Officer	Buy	166,666	$0.30	$49,999.80	+340.1%	-13.7%	-99.2%
Feb 1, 2024	Gumulka Jerzy	Director	Buy	33,333	$0.30	$9,999.90	+344.6%	-13.7%	-99.2%
Aug 22, 2023	Downs Christopher	Chief Financial Officer	Buy	27,000	$1.27	$34,176.60	+276.3%	+41.4%	-99.8%
Aug 16, 2023	Climaco John M	Chief Executive Officer	Buy	2,750	$1.80	$4,944.50	+5.9%	-8.2%	-99.8%
Apr 19, 2023	Gumulka Jerzy	Director	Buy	2,500	$1.70	$4,250.00	+34.9%	+18.6%	-88.5%
Apr 17, 2023	Downs Christopher	Chief Financial Officer	Buy	3,100	$3.20	$9,920.00	+50.4%	-22.2%	-92.4%
Apr 12, 2023	Climaco John M	Chief Executive Officer	Buy	15,000	$0.69	$10,408.50	+50.0%	+240.7%	-64.8%